Huvy, founded in 2021 by Léonie Schröder and Bryan Boulé and based in Nantes, has developed an AI-driven solution for melanoma screening. Patients take a photo of a mole and submit it to an app that analyzes the image in real time and produces an instant recommendation. The professional receives the analysis and can combine it with patient history to inform decisions, including referral to a dermatologist. Clinical tests reported the tool determines risk with 95% accuracy, and the company expects algorithm performance to improve with further training. Huvy positions the product to improve access to care and to pre-triage cases, optimizing specialist time on complex cases. The startup plans to advance regulatory work toward European medical device certification and aims to commercialize during 2024. It is supported by incubators IMT Starter and La Rochelle Technopole.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2023